CXCR2 and triple-negative breast carcinoma: It has been reported that in triple-negative breast cancer, the expression of CXCR2 is associated with higher immune infiltration and more favorable outcomes [24], whereas CXCR2 ligands have been reported to have cancer-promoting effects [25–27].